Q2 2024 – Leukemia & Lymphoma Society

For Q2 of 2024, AG2 has chosen the Leukemia & Lymphoma Society to receive a $2500 donation

The Leukemia & Lymphoma Society is the largest nonprofit funder of leading-edge research for every type of blood cancer, including leukemia, lymphoma, myeloma, and other rare types of blood cancers. They make thoughtful investments in blood cancer research that will lead to scientific breakthroughs that will improve and save the lives of patients. The LLS Research Team oversees the organization’s research agenda and manages our portfolio to support cutting-edge research for every type of blood cancer.

Share this